BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1424 related articles for article (PubMed ID: 16219412)

  • 1. Epigenetic control of ovarian function: the emerging role of histone modifications.
    LaVoie HA
    Mol Cell Endocrinol; 2005 Nov; 243(1-2):12-8. PubMed ID: 16219412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus type 16 E7 protein increases acetylation of histone H3 in human foreskin keratinocytes.
    Zhang B; Laribee RN; Klemsz MJ; Roman A
    Virology; 2004 Nov; 329(1):189-98. PubMed ID: 15476886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental regulation of histone H3 methylation at lysine 4 in the porcine ovary.
    Seneda MM; Godmann M; Murphy BD; Kimmins S; Bordignon V
    Reproduction; 2008 Jun; 135(6):829-38. PubMed ID: 18502896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics and the estrogen receptor.
    Leader JE; Wang C; Popov VM; Fu M; Pestell RG
    Ann N Y Acad Sci; 2006 Nov; 1089():73-87. PubMed ID: 17261756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
    Vaissière T; Sawan C; Herceg Z
    Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of transcription of the steroidogenic acute regulatory protein (StAR) gene: temporal and spatial changes in transcription factor binding and histone modification.
    Hiroi H; Christenson LK; Strauss JF
    Mol Cell Endocrinol; 2004 Feb; 215(1-2):119-26. PubMed ID: 15026184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone acetylation and methylation: combinatorial players for transcriptional regulation.
    An W
    Subcell Biochem; 2007; 41():351-69. PubMed ID: 17484136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylases, transcriptional control, and cancer.
    Cress WD; Seto E
    J Cell Physiol; 2000 Jul; 184(1):1-16. PubMed ID: 10825229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone acetylation in gene regulation.
    Verdone L; Agricola E; Caserta M; Di Mauro E
    Brief Funct Genomic Proteomic; 2006 Sep; 5(3):209-21. PubMed ID: 16877467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic regulation of airway inflammation.
    Adcock IM; Tsaprouni L; Bhavsar P; Ito K
    Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of NuA4 histone acetyltransferase activity in transcription and DNA repair by phosphorylation of histone H4.
    Utley RT; Lacoste N; Jobin-Robitaille O; Allard S; Côté J
    Mol Cell Biol; 2005 Sep; 25(18):8179-90. PubMed ID: 16135807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatin remodeling, histone modifications, and DNA methylation-how does it all fit together?
    Geiman TM; Robertson KD
    J Cell Biochem; 2002; 87(2):117-25. PubMed ID: 12244565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone modification enzymes: novel targets for cancer drugs.
    Kristeleit R; Stimson L; Workman P; Aherne W
    Expert Opin Emerg Drugs; 2004 May; 9(1):135-54. PubMed ID: 15155140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats.
    Ke X; Lei Q; James SJ; Kelleher SL; Melnyk S; Jernigan S; Yu X; Wang L; Callaway CW; Gill G; Chan GM; Albertine KH; McKnight RA; Lane RH
    Physiol Genomics; 2006 Mar; 25(1):16-28. PubMed ID: 16380407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of gene silencing as a therapeutic target for cancer--roles for DNA methylation and its interdigitation with chromatin.
    Baylin SB
    Novartis Found Symp; 2004; 259():226-33; discussion 234-7, 285-8. PubMed ID: 15171257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation and chromatin - unraveling the tangled web.
    Robertson KD
    Oncogene; 2002 Aug; 21(35):5361-79. PubMed ID: 12154399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific and imprinted epigenetic modifications of the human NDN gene.
    Lau JC; Hanel ML; Wevrick R
    Nucleic Acids Res; 2004; 32(11):3376-82. PubMed ID: 15247330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
    Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
    Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone modifying enzymes and cancer: going beyond histones.
    Zhang K; Dent SY
    J Cell Biochem; 2005 Dec; 96(6):1137-48. PubMed ID: 16173079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.